Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of General, Visceral, Cancer and Transplant Surgery, Faculty of Medicine, University of Cologne, Cologne, Germany.
Dis Esophagus. 2023 Oct 27;36(11). doi: 10.1093/dote/doad027.
Anastomotic leakage (AL) after esophagectomy is the most impactful complication after esophagectomy. Ischemic conditioning (ISCON) of the stomach >14 days prior to esophagectomy might reduce the incidence of AL. The current trial was conducted to prospectively investigate the safety and feasibility of laparoscopic ISCON in selected patients. This international multicenter feasibility trial included patients with esophageal cancer at high risk for AL with major calcifications of the thoracic aorta or a stenosis in the celiac trunk. Patients underwent laparoscopic ISCON by occlusion of the left gastric and the short gastric arteries followed by esophagectomy after an interval of 12-18 days. The primary endpoint was complications Clavien-Dindo ≥ grade 2 after ISCON and before esophagectomy. Between November 2019 and January 2022, 20 patients underwent laparoscopic ISCON followed by esophagectomy. Out of 20, 16 patients (80%) underwent neoadjuvant treatment. The median duration of the laparoscopic ISCON procedure was 45 minutes (range: 25-230). None of the patients developed intraoperative or postoperative complications after ISCON. Hospital stay after ISCON was median 2 days (range: 2-4 days). Esophagectomy was completed in all patients after a median of 14 days (range: 12-28). AL occurred in three patients (15%), and gastric tube necrosis occurred in one patient (5%). In hospital, the 30-day and 90-day mortalities were 0%. Laparoscopic ISCON of the gastric conduit is feasible and safe in selected esophageal cancer patients with an impaired vascular status. Further studies have to prove whether this innovative strategy aids to reduce the incidence of AL.
食管切除术后吻合口漏(AL)是食管切除术后最具影响力的并发症。在食管切除术前 14 天以上对胃进行缺血预处理(ISCON)可能会降低 AL 的发生率。本试验旨在前瞻性研究选择的患者中腹腔镜 ISCON 的安全性和可行性。这项国际多中心可行性试验纳入了有 AL 高危风险的食管癌患者,这些患者的胸主动脉有严重钙化或腹腔干狭窄。患者接受腹腔镜 ISCON 治疗,通过阻断胃左动脉和胃短动脉,然后在 12-18 天后进行食管切除术。主要终点是 ISCON 后和食管切除术前 Clavien-Dindo 分级≥2 的并发症。2019 年 11 月至 2022 年 1 月,20 例患者接受了腹腔镜 ISCON 治疗,然后进行食管切除术。20 例患者中,16 例(80%)接受了新辅助治疗。腹腔镜 ISCON 手术的中位时间为 45 分钟(范围:25-230 分钟)。ISCON 后无患者发生术中或术后并发症。ISCON 后住院中位时间为 2 天(范围:2-4 天)。所有患者在中位 14 天后(范围:12-28 天)完成了食管切除术。有 3 例患者(15%)发生吻合口漏,1 例患者(5%)发生胃管坏死。住院期间,30 天和 90 天死亡率均为 0%。在选择的血管状态受损的食管癌患者中,腹腔镜 ISCON 是可行且安全的。进一步的研究需要证明这种创新策略是否有助于降低 AL 的发生率。